BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26657058)

  • 1. Transient receptor potential channel C5 in cancer chemoresistance.
    He DX; Ma X
    Acta Pharmacol Sin; 2016 Jan; 37(1):19-24. PubMed ID: 26657058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium Signaling and the Regulation of Chemosensitivity in Cancer Cells: Role of the Transient Receptor Potential Channels.
    Santoni G; Morelli MB; Marinelli O; Nabissi M; Santoni M; Amantini C
    Adv Exp Med Biol; 2020; 1131():505-517. PubMed ID: 31646523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells.
    Shimizu S; Yoshida T; Wakamori M; Ishii M; Okada T; Takahashi M; Seto M; Sakurada K; Kiuchi Y; Mori Y
    J Physiol; 2006 Jan; 570(Pt 2):219-35. PubMed ID: 16284075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite regulatory effects of TRPC1 and TRPC5 on neurite outgrowth in PC12 cells.
    Heo DK; Chung WY; Park HW; Yuan JP; Lee MG; Kim JY
    Cell Signal; 2012 Apr; 24(4):899-906. PubMed ID: 22201561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar phospholipid sensing by TRPC5 calcium channel.
    Beech DJ
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):101-4. PubMed ID: 17233612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Wang T; Ning K; Lu TX; Hua D
    Oncol Rep; 2017 Feb; 37(2):1059-1065. PubMed ID: 28000878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing circulating exosomes-carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients.
    Wang T; Ning K; Lu TX; Sun X; Jin L; Qi X; Jin J; Hua D
    Cancer Sci; 2017 Mar; 108(3):448-454. PubMed ID: 28032400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRP channels in disease.
    Nilius B; Voets T; Peters J
    Sci STKE; 2005 Aug; 2005(295):re8. PubMed ID: 16077087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane mechanical stress activates TRPC5 channels.
    Shen B; Wong CO; Lau OC; Woo T; Bai S; Huang Y; Yao X
    PLoS One; 2015; 10(4):e0122227. PubMed ID: 25849346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses.
    Schwarz Y; Oleinikov K; Schindeldecker B; Wyatt A; Weißgerber P; Flockerzi V; Boehm U; Freichel M; Bruns D
    PLoS Biol; 2019 Sep; 17(9):e3000445. PubMed ID: 31536487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure.
    Xu SZ; Zeng B; Daskoulidou N; Chen GL; Atkin SL; Lukhele B
    Toxicol Sci; 2012 Jan; 125(1):56-68. PubMed ID: 21984481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells.
    Dong Y; Pan Q; Jiang L; Chen Z; Zhang F; Liu Y; Xing H; Shi M; Li J; Li X; Zhu Y; Chen Y; Bruce IC; Jin J; Ma X
    Biochem Biophys Res Commun; 2014 Mar; 446(1):85-90. PubMed ID: 24582564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC5.
    Zholos AV
    Handb Exp Pharmacol; 2014; 222():129-56. PubMed ID: 24756705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of TRPC5 cationic channels by low micromolar concentrations of lead ions (Pb2+).
    Sukumar P; Beech DJ
    Biochem Biophys Res Commun; 2010 Feb; 393(1):50-4. PubMed ID: 20100462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trpc5 deficiency causes hypoprolactinemia and altered function of oscillatory dopamine neurons in the arcuate nucleus.
    Blum T; Moreno-Pérez A; Pyrski M; Bufe B; Arifovic A; Weissgerber P; Freichel M; Zufall F; Leinders-Zufall T
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15236-15243. PubMed ID: 31285329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
    Jiang H; Zeng B; Chen GL; Bot D; Eastmond S; Elsenussi SE; Atkin SL; Boa AN; Xu SZ
    Biochem Pharmacol; 2012 Apr; 83(7):923-31. PubMed ID: 22285229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase C-coupled receptors and activation of TRPC channels.
    Trebak M; Lemonnier L; Smyth JT; Vazquez G; Putney JW
    Handb Exp Pharmacol; 2007; (179):593-614. PubMed ID: 17217081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5.
    Richter JM; Schaefer M; Hill K
    Mol Pharmacol; 2014 Nov; 86(5):514-21. PubMed ID: 25140002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.
    Pablo JL; Greka A
    Trends Pharmacol Sci; 2019 Dec; 40(12):911-918. PubMed ID: 31704171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.